America’s salesman-in-chief capitalized on the most lucrative pitch of his life. Now Trump is selling something else—the myth that he doesn’t know how he made so much.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars is ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Mercedes-Benz Stadium is one of the most innovative sports and entertainment venues in the world. In this episode of Stadium Wonders, Sports Illustrated Staff Writer Dan Gartland goes behind the ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Looks like this might be my new “oh, damn, the sun is up?” game The eighth big update brings crossplay, photo mode, new subclasses, and more We’ll get you through Episode: Echoes’ hardest challenge, ...

Intel Is Making Progress. But It Isn’t Out of the Woods Yet. A shift in the AI market helps the chip maker, but the stock has already tripled while Intel’s turnaround is far from done.

Dan Neil is the author of the “Rumble Seat” column which runs Saturdays in The Wall Street Journal. Previously, Mr. Neil was the auto columnist for the Los Angeles Times from 2003 to 2010. He also ...

The ruling reversed a decision by the state’s elections office that had found Dan J. Sullivan was ineligible to challenge Dan S. Sullivan, an incumbent senator. By Tim Balk Alaska voters may have two ...